Search research articles
Contact Us
Filters
Showing results (101-110 of 158) with videos related to
Page
of 16
Sort By:
Plos One
|
February 6, 2014
The relation of rapid changes in obesity measures to lipid profile - insights from a nationwide metabolic health survey in 444 Polish cities
Bernhard M Kaess, Jacek Jóźwiak, Christopher P Nelson, et al.
Journal of the National Cancer Institute
|
November 6, 2010
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women
Andrea Z LaCroix, Trevor Powles, C Kent Osborne, et al.
Ebiomedicine
|
July 25, 2021
Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank
Qingning Wang, Veryan Codd, Zahra Raisi-Estabragh, et al.
The Review of Scientific Instruments
|
July 5, 2013
Architecture, implementation, and testing of a multiple-shell gas injection system for high current implosions on the Z accelerator
Mahadevan Krishnan, Kristi Wilson Elliott, Robert E Madden, et al.
Plos Medicine
|
June 11, 2013
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study
Irene Pichler, Fabiola Del Greco M, Martin Gögele, et al.
European Journal of Epidemiology
|
June 19, 2017
Age at menarche and lung function: a Mendelian randomization study
Dipender Gill, Nuala A Sheehan, Matthias Wielscher, et al.
Plos Medicine
|
January 14, 2021
Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses
Luanluan Sun, Lisa Pennells, Stephen Kaptoge, et al.
Plos One
|
September 17, 2013
Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21
Eric S Muise, Sandra Souza, An Chi, et al.
Journal of Medicinal Chemistry
|
June 11, 2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volume
John J Acton, Taro E Akiyama, Ching H Chang, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 3, 2017
Risk Factors for Nonadherence to Antihypertensive Treatment
Pankaj Gupta, Prashanth Patel, Branislav Štrauch, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 158) with videos related to
Sort By:
Page
of 16
Plos One
|
February 6, 2014
The relation of rapid changes in obesity measures to lipid profile - insights from a nationwide metabolic health survey in 444 Polish cities
Bernhard M Kaess, Jacek Jóźwiak, Christopher P Nelson, et al.
Journal of the National Cancer Institute
|
November 6, 2010
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women
Andrea Z LaCroix, Trevor Powles, C Kent Osborne, et al.
Ebiomedicine
|
July 25, 2021
Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank
Qingning Wang, Veryan Codd, Zahra Raisi-Estabragh, et al.
The Review of Scientific Instruments
|
July 5, 2013
Architecture, implementation, and testing of a multiple-shell gas injection system for high current implosions on the Z accelerator
Mahadevan Krishnan, Kristi Wilson Elliott, Robert E Madden, et al.
Plos Medicine
|
June 11, 2013
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study
Irene Pichler, Fabiola Del Greco M, Martin Gögele, et al.
European Journal of Epidemiology
|
June 19, 2017
Age at menarche and lung function: a Mendelian randomization study
Dipender Gill, Nuala A Sheehan, Matthias Wielscher, et al.
Plos Medicine
|
January 14, 2021
Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses
Luanluan Sun, Lisa Pennells, Stephen Kaptoge, et al.
Plos One
|
September 17, 2013
Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21
Eric S Muise, Sandra Souza, An Chi, et al.
Journal of Medicinal Chemistry
|
June 11, 2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volume
John J Acton, Taro E Akiyama, Ching H Chang, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 3, 2017
Risk Factors for Nonadherence to Antihypertensive Treatment
Pankaj Gupta, Prashanth Patel, Branislav Štrauch, et al.
Page
of 16